Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study

URN to cite this document:: urn:nbn:de:bvb:355-epub-580380
DOI to cite this document:: 10.5283/epub.58038

Kollerits, Barbara ; Gruber, Simon ; Steinbrenner, Inga ; Schwaiger, Johannes P. ; Weissensteiner, Hansi ; Schönherr, Sebastian ; Forer, Lukas ; Kotsis, Fruzsina ; Schultheiss, Ulla T. ; Meiselbach, Heike ; Wanner, Christoph ; Eckardt, Kai-Uwe ; Kronenberg, Florian ; Oefner, Peter J. ; Gronwald, Wolfram

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 08 Apr 2024 07:09

Alternative links to fulltext:Pubmed DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Background Chronic kidney disease (CKD) is highly connected to inflammation and oxidative stress. Both favour the development of cancer in CKD patients. Serum apolipoprotein A-IV (apoA-IV) concentrations are influenced by kidney function and are an early marker of kidney impairment. Besides others, it has antioxidant and anti-inflammatory properties. Proteomic studies and small case–control ...